HYBRID EVENT: You can participate in person at Orlando, Florida, USA or Virtually from your home or work.

12th Edition of International Conference on Neurology and Brain Disorders

October 20-22, 2025

October 20 -22, 2025 | Orlando, Florida, USA

Motor Neuron Diseases

Motor Neuron Diseases

Motor neuron diseases (MNDs) are a group of progressive neurological disorders that affect the motor neurons in the brain and spinal cord. The motor neurons are responsible for controlling voluntary muscle movement such as speaking, walking, and breathing. Over time, MNDs can result in muscle weakness and paralysis. The causes of MNDs are not completely understood. Some forms of MNDs run in families, while others are caused by exposure to toxic substances or infections. Exposure to environmental factors like toxins or excess stress may increase with susceptibility to MNDs. Mylestated diseases, amyotrophic lateral sclerosis (ALS), progressive muscular atrophy (PMA), primary lateral sclerosis (PLS), progressive bulbar palsy (PBP), primary muscular atrophy (PMA) and inherited motor neuron syndromes such as hereditary motor neuron pathology (HMN) are some common types of MNDs. Symptoms of MNDs may vary from one individual to another depending on the specific disorder. In general, the most common symptom is muscle weakness and/or paralysis, which can begin in the limited area such as a single hand or foot and progress to other parts of the body. Additional symptoms can include muscle wasting, twitching, stiffness, difficulty in speaking and swallowing, and difficulty in breathing. Diagnosis of MNDs is done through a physical examination, imaging tests, blood and urine tests, and a number of nerve tests. Treatment options for MNDs vary depending on the disorder and severity of the symptoms. Medications may be used to slow down the progression of the disease, while physical therapy, occupational therapy, and supportive devices such as braces and wheelchairs can help maintain muscle function. In some cases, surgery and stem cell therapy may also be recommended. The prognosis for MNDs is typically worse than other types of neurological disorders because of the progressive nature of the disorder. However, with the use of early diagnosis and the right treatment, the progression of MNDs can be slowed down and the affected individuals can live longer and more comfortable lives.

Committee Members
Speaker at Neuroscience Conference - Ken Ware

Ken Ware

NeuroPhysics Therapy Institute and Research Centre, Australia
Speaker at Neurology and Brain Disorders - Joe Sam Robinson

Joe Sam Robinson

Mercer University, United States
Speaker at Neurology Conferences - Robert B Slocum

Robert B Slocum

University of Kentucky HealthCare, United States
INBC 2025 Speakers
Speaker at Brain Disorders Conference - Thomas J Webster

Thomas J Webster

Interstellar Therapeutics, United States
Speaker at Neuroscience Conference - Roger H Coletti

Roger H Coletti

Interventional Health, PA, United States
Speaker at Neuroscience Conference - Stephen Grossberg

Stephen Grossberg

Boston University, United States
Speaker at Brain Disorders Conference - George Diaz

George Diaz

Memorial Healthcare Systems, United States

Submit your abstract Today

Watsapp